Related Experiment Video
Updated: May 22, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Cannabinoids: novel therapies for arthritis?
Sara L Dunn1, J Mark Wilkinson, Aileen Crawford
1Biomedical Research Centre, Faculty of Health and Wellbeing, Sheffield Hallam University, Sheffield, S1 1WB, UK.
Future Medicinal Chemistry
|April 26, 2012
Summary
Cannabinoids may protect joints by preventing cartilage breakdown in arthritis. Research is exploring these compounds and their receptors for future anti-arthritic treatments.
Area of Science:
- Rheumatology
- Pharmacology
- Biochemistry
Background:
- Osteoarthritis and rheumatoid arthritis involve articular cartilage loss.
- Cartilage breakdown is driven by cytokines (e.g., IL-1), inflammatory mediators (e.g., nitric oxide, prostaglandin E2), and proteases (e.g., matrix metalloproteinases, ADAMTS-4/5).
Purpose of the Study:
- To review the chondroprotective effects of cannabinoids in arthritis.
- To identify key cannabinoids and receptors involved in preventing cartilage breakdown.
- To outline the therapeutic potential of cannabinoids for arthritis.
Main Methods:
- Review of existing literature on cannabinoid effects in arthritis models.
- Analysis of studies investigating cannabinoid interactions with inflammatory pathways and cartilage matrix components.
- Examination of cannabinoid receptor signaling in chondrocytes.
Main Results:
- Cannabinoids demonstrate joint damage reduction in animal arthritis models.
- Cannabinoids inhibit IL-1-induced breakdown of collagen and proteoglycan.
- Cannabinoid-mediated chondroprotection involves specific cannabinoid receptors.
Conclusions:
- Cannabinoids show promise as anti-arthritic therapeutics.
- Targeting cannabinoid receptors may offer a novel strategy for preventing cartilage degradation.
- Further research is needed to elucidate specific cannabinoid mechanisms for therapeutic development.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...